Evidence map›Paper›PMID 34136065›Full record

ArticleOxidative medicine and cellular longevity2021

Hypoxia Induced by Cobalt Chloride Triggers Autophagic Apoptosis of Human and Mouse Drug-Resistant Glioblastoma Cells through Targeting the PI3K-AKT-mTOR Signaling Pathway.

Yuan-Wen Lee, Yih-Giun Cherng, Shun-Tai Yang, Shing-Hwa Liu, Ta-Liang Chen, Ruei-Ming Chen

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Formyl Peptide Receptor-2-Suppressed Autophagy Promotes the Migration and Invasion of Human Glioblastoma Cells Through PI3K/Akt Signaling.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Prosthetic Metals: Release, Metabolism and Toxicity.International journal of nanomedicine · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yuan-Wen LeeAnesthesiology and Health Policy Research Center; Department of Anesthesiology, Taipei Medical University Hospital, Taipei Medical University, Taipei 110, Taiwan.
Yih-Giun CherngDepartment of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Shun-Tai YangDepartment of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan.
Shing-Hwa LiuInstitute of Toxicology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Ta-Liang ChenDepartment of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Ruei-Ming ChenAnesthesiology and Health Policy Research Center; Department of Anesthesiology, Taipei Medical University Hospital, Taipei Medical University, Taipei 110, Taiwan.ORCID https://orcid.org/0000-0002-5728-0571
Taipei Medical University Hospital · TWTaipei Medical University-Shuang Ho Hospital · TWNational Taiwan University · TWWan Fang Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) is the most aggressive brain tumor. Drug resistance mainly drives GBM patients to poor prognoses because drug-resistant glioblastoma cells highly defend against apoptotic insults. This study was designed to evaluate the effects of cobalt chloride (CoCl

Indexed as

AnimalsApoptosisBrain NeoplasmsCell HypoxiaCell Line, TumorCell ProliferationCobaltGlioblastomaHumansMicePhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesSignal TransductionCobaltcobaltous chloridePhosphatidylinositol 3-KinasePhosphatidylinositol 3-Kinases

Identifiers

PMID34136065
PMCPMC8177987
OpenAlexW3173008139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.